London Daily

Focus on the big picture.
Wednesday, Oct 22, 2025

UK cannabis campaigners take note: in the US, change came from below

UK cannabis campaigners take note: in the US, change came from below

Sadiq Khan’s decriminalisation commission could put pressure on the government to change its policy
Take a stroll down Abbot Kinney Boulevard, the high street for hipsters in Venice Beach, California, and alongside the brightly painted boutiques offering vintage T-shirts or oat-spiced lattes, you’ll find a sleek, bright red storefront with plate-glass windows that, at first glance, is easy to mistake for a car showroom.

Instead of cars, though, it sells high-end cannabis products: Huckleberry Gummies, Keef root beer, concentrates, creams and lotions, rolled joints and vaporisers, all laid out on carefully curated wooden tables. This is MedMen, part of a national chain of quality pot shops that constitute the normal now that cannabis is authorised for recreational and medical use in California and 16 other states.

Sadiq Khan, the mayor of London, may have pledged to set up an independent commission to study decriminalisation, but to anyone familiar with the largely stalled debate over cannabis in Britain, the proliferation of legal pot shops along well-trafficked thoroughfares is an exotic and improbable sight. California is far from a perfect model to follow, not least because of its ferociously complex patchwork of regulations and requirements that vary from city to city, and other states have struggled with their own problems in setting up the infrastructure of a newly legal industry. Having set off down the road toward full legalisation almost 30 years ago, though, America does have some salient lessons to offer.

First, contrary to the fears of drug alarmists, the ready availability of cannabis products has not been shown to have any significant effect on crime, addiction or traffic accident statistics. Rather, if established and regulated properly, the legal market brings a previously clandestine activity into the open and makes it safer and more accountable.

Second, there’s no virtue in half-measures. Like Britain, many US states started off attempting to restrict legalisation to medical use. But it was only after Colorado and Washington became the first states to open to legal recreational use in 2012 that any meaningful market emerged to challenge the old criminal networks.

A medical marijuana market may have been a theoretical possibility, but in practice government agencies have been reluctant to create one because many of the key decision-makers continued to feel that cannabis was – to use Boris Johnson’s term – a “harmful substance”. At the same time, doctors with no training in the drug’s uses felt no compulsion to prescribe it, which is exactly what Britain has experienced since giving the green light to medical use in late 2018.

In many ways, the UK is now where the US was 20 years ago, when the only legally recognised distributor of medical cannabis was, improbably, a lab at the University of Mississippi in the ultra-conservative deep south that proved powerless to challenge the long-established dominance of the black market.

The lab didn’t manufacture suppositories or gels or edibles. It made no effort to separate out THC, the psychoactive ingredient that gets users high, and cannabidiol, or CBD, whose benefits are said to include everything from pain relief and heart health to treatment for depression, diabetes and acne.

Rather, the lab sent out metal canisters, each containing 300 rolled joints for recipients to use as they saw fit. Many of them would unroll the joints again to pick out seeds and other extraneous material that didn’t burn smoothly, and even then they complained that the cannabis itself was of low quality.

As of the early 2000s, just four people were receiving this service – out of a population then pushing close to 300 million. Those dismal numbers are broadly in line with the findings of a report by a UK cannabis industry group last month that said NHS doctors had issued just three cannabis prescriptions in the two years since legalisation, and private-sector doctors had written just a few thousand. An estimated 1.4 million people, meanwhile, are estimated to be self-medicating with cannabis bought off the street.

Lesson number three from across the Atlantic is that the most effective way to break an impasse of this sort is through pressure from below – much as Sadiq Khan is seeking to pressure the government with his commission. Building a legal cannabis industry from scratch is a daunting prospect – much harder than it was, for example, for the United States to re-regulate the alcohol industry after the end of prohibition in the 1930s – and governments have a natural tendency to prefer the status quo, however unsatisfactory or unpopular, to plunging into the unknown.

Since the 1990s, the pressure for change in the US has come through popular referendums, known as ballot initiatives, that have set pioneering states such as California and Colorado on a collision course with the federal government. One of the peculiarities of the US system, in fact, is that while much of the country has approved legalisation of cannabis, the federal government still regards it as a controlled substance to be used only in tightly defined circumstances. That, in turn, has forced the new wave of entrepreneurs to operate in a weird legal limbo, caught between state and federal systems. Many of them are cash only, since the federal government sets banking rules, and they are unable deduct most business expenses from their federal taxes.

Still, the tide is slowly turning. Business operators are no longer at risk of being raided by federal agents, as they were in the 1990s and early 2000s, and industry lobbyists have been working steadily to relax the banking rules.

Which leads to lesson number four: that even under the best of circumstances the legalisation process is likely to be lengthy and complicated. It’s no coincidence that in California the most visible businesses are at the luxury end of the market. Red tape and high taxes have scared many other operators away, to the frustration of entrepreneurs in lower-income, African American communities that were hit hard by America’s long, punitive war on drugs and are now yearning for some modicum of compensatory justice. Instead, they see a black market continuing to thrive.

The point, though, is to start somewhere. In the early days, Washington told many states – just as Downing Street has told Khan – that campaigning for broad legalisation was a waste of time because they didn’t set drug policy. If the states had listened, US consumers would never have gained access to the sort of high-quality products and expert guidance available at MedMen and other outlets. They’d still be waiting for their canisters from the University of Mississippi – or, more likely, scoring their hits on the street.
Newsletter

Related Articles

0:00
0:00
Close
US Administration Under President Donald Trump Reportedly Lifts Ban on Ukraine’s Use of Storm Shadow Missiles Against Russia
‘Frightening’ First Night in Prison for Sarkozy: Inmates Riot and Shout ‘Little Nicolas’
White House Announces No Imminent Summit Between Trump and Putin
US and Qatar Warn EU of Trade and Energy Risks from Tough Climate Regulation
Apple Challenges EU Digital Markets Act Crackdown in Landmark Court Battle
Nicolas Sarkozy begins five-year prison term at La Santé in Paris
Japan stocks surge to record as Sanae Takaichi becomes Prime Minister
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
×